Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hcfc1
|
ENSMUSG00000031386.8 | host cell factor C1 |
Six5
|
ENSMUSG00000040841.5 | sine oculis-related homeobox 5 |
Smarcc2
|
ENSMUSG00000025369.8 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 |
Zfp143
|
ENSMUSG00000061079.7 | zinc finger protein 143 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_73967541_73967927 | Hcfc1 | 1377 | 0.283541 | 0.91 | 1.4e-21 | Click! |
chrX_73967214_73967397 | Hcfc1 | 948 | 0.410246 | 0.76 | 1.7e-11 | Click! |
chrX_73966913_73967094 | Hcfc1 | 646 | 0.570230 | 0.74 | 1.4e-10 | Click! |
chrX_73969323_73969517 | Hcfc1 | 3063 | 0.148876 | 0.71 | 1.6e-09 | Click! |
chrX_73965274_73965603 | Hcfc1 | 913 | 0.424695 | 0.71 | 1.6e-09 | Click! |
chr7_19096455_19096727 | Six5 | 1997 | 0.134857 | -0.52 | 5.7e-05 | Click! |
chr7_19094759_19096427 | Six5 | 999 | 0.281530 | -0.42 | 1.6e-03 | Click! |
chr7_19097458_19097691 | Six5 | 2980 | 0.100118 | -0.32 | 1.9e-02 | Click! |
chr7_19097269_19097443 | Six5 | 2762 | 0.104954 | -0.24 | 8.1e-02 | Click! |
chr7_19094102_19094571 | Six5 | 258 | 0.780376 | -0.21 | 1.2e-01 | Click! |
chr10_128459263_128459897 | Smarcc2 | 76 | 0.890474 | 0.76 | 2.7e-11 | Click! |
chr7_110061466_110062232 | Zfp143 | 127 | 0.832364 | 0.92 | 7.9e-23 | Click! |
chr7_110061019_110061438 | Zfp143 | 11 | 0.572042 | 0.91 | 8.2e-22 | Click! |
chr7_110060429_110060580 | Zfp143 | 713 | 0.386498 | 0.50 | 9.8e-05 | Click! |
chr7_110096317_110096468 | Zfp143 | 4763 | 0.139334 | 0.26 | 5.2e-02 | Click! |
chr7_110097692_110097843 | Zfp143 | 6138 | 0.130907 | -0.15 | 2.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_71211269_71211777 | 34.99 |
Dync1i2 |
dynein cytoplasmic 1 intermediate chain 2 |
183 |
0.96 |
chr8_121950071_121950243 | 32.76 |
Banp |
BTG3 associated nuclear protein |
335 |
0.55 |
chr9_19621805_19622062 | 29.20 |
Zfp317 |
zinc finger protein 317 |
169 |
0.92 |
chr1_72583067_72583257 | 28.07 |
Smarcal1 |
SWI/SNF related matrix associated, actin dependent regulator of chromatin, subfamily a-like 1 |
89 |
0.97 |
chr11_4704553_4704732 | 26.85 |
Zmat5 |
zinc finger, matrin type 5 |
36 |
0.81 |
chr12_91384377_91384654 | 26.43 |
Tshr |
thyroid stimulating hormone receptor |
48 |
0.57 |
chr5_149636665_149636846 | 26.42 |
Hsph1 |
heat shock 105kDa/110kDa protein 1 |
379 |
0.81 |
chr6_124828897_124829217 | 26.39 |
Usp5 |
ubiquitin specific peptidase 5 (isopeptidase T) |
162 |
0.75 |
chr15_76351660_76351840 | 24.06 |
Maf1 |
MAF1 homolog, negative regulator of RNA polymerase III |
256 |
0.66 |
chr9_78108999_78109178 | 23.68 |
Fbxo9 |
f-box protein 9 |
23 |
0.58 |
chr2_167634484_167634690 | 23.43 |
Ube2v1 |
ubiquitin-conjugating enzyme E2 variant 1 |
2492 |
0.16 |
chr14_64949310_64950069 | 23.17 |
Hmbox1 |
homeobox containing 1 |
57 |
0.83 |
chr1_86582766_86582950 | 23.11 |
Cops7b |
COP9 signalosome subunit 7B |
46 |
0.73 |
chr10_81496310_81496645 | 21.99 |
Ncln |
nicalin |
85 |
0.91 |
chr16_55934464_55934638 | 21.89 |
Cep97 |
centrosomal protein 97 |
71 |
0.95 |
chr15_81729551_81730236 | 21.84 |
Rangap1 |
RAN GTPase activating protein 1 |
8 |
0.96 |
chr11_29548130_29548316 | 21.23 |
Rps27a |
ribosomal protein S27A |
114 |
0.61 |
chr7_128461619_128462007 | 21.03 |
Tial1 |
Tia1 cytotoxic granule-associated RNA binding protein-like 1 |
96 |
0.71 |
chr1_176814662_176814841 | 20.76 |
Sdccag8 |
serologically defined colon cancer antigen 8 |
91 |
0.89 |
chr12_106009997_106010356 | 20.75 |
Vrk1 |
vaccinia related kinase 1 |
52 |
0.98 |
chr3_87885526_87885977 | 20.70 |
Prcc |
papillary renal cell carcinoma (translocation-associated) |
143 |
0.92 |
chr15_57892002_57892200 | 20.67 |
Derl1 |
Der1-like domain family, member 1 |
347 |
0.89 |
chr3_121291927_121292619 | 20.39 |
Alg14 |
asparagine-linked glycosylation 14 |
383 |
0.82 |
chr4_107367673_107367855 | 20.15 |
Ndc1 |
NDC1 transmembrane nucleoporin |
20 |
0.97 |
chr12_87265855_87266497 | 20.10 |
Vipas39 |
VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog |
33 |
0.77 |
chr12_83597130_83597511 | 20.04 |
Zfyve1 |
zinc finger, FYVE domain containing 1 |
98 |
0.96 |
chr2_166996113_166996491 | 19.85 |
Stau1 |
staufen double-stranded RNA binding protein 1 |
3 |
0.96 |
chr2_77946309_77946705 | 19.78 |
Cwc22 |
CWC22 spliceosome-associated protein |
132 |
0.97 |
chr5_136962284_136962476 | 19.36 |
Fis1 |
fission, mitochondrial 1 |
53 |
0.94 |
chr7_92741445_92741816 | 19.20 |
Rab30 |
RAB30, member RAS oncogene family |
27 |
0.66 |
chr17_35673689_35674031 | 18.61 |
Gtf2h4 |
general transcription factor II H, polypeptide 4 |
121 |
0.9 |
chr12_71830909_71831677 | 18.41 |
Daam1 |
dishevelled associated activator of morphogenesis 1 |
130 |
0.97 |
chr13_44730541_44730901 | 18.23 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
53 |
0.98 |
chr2_101628931_101629119 | 18.12 |
B230118H07Rik |
RIKEN cDNA B230118H07 gene |
16 |
0.97 |
chr4_116708308_116709152 | 18.11 |
Ccdc163 |
coiled-coil domain containing 163 |
26 |
0.82 |
chr2_118598069_118598262 | 18.07 |
Bub1b |
BUB1B, mitotic checkpoint serine/threonine kinase |
46 |
0.97 |
chr1_60097846_60098019 | 18.02 |
Wdr12 |
WD repeat domain 12 |
24 |
0.82 |
chr4_43039190_43039488 | 17.94 |
Fam214b |
family with sequence similarity 214, member B |
8 |
0.96 |
chr8_91313211_91313605 | 17.80 |
Fto |
fat mass and obesity associated |
117 |
0.53 |
chr15_102722057_102722434 | 17.67 |
Calcoco1 |
calcium binding and coiled coil domain 1 |
67 |
0.96 |
chr5_34659992_34660366 | 17.60 |
Nop14 |
NOP14 nucleolar protein |
31 |
0.71 |
chr14_64950156_64950354 | 17.55 |
Ints9 |
integrator complex subunit 9 |
47 |
0.85 |
chr10_86705983_86706165 | 16.68 |
Ttc41 |
tetratricopeptide repeat domain 41 |
230 |
0.62 |
chr5_123720940_123721389 | 16.67 |
Zcchc8 |
zinc finger, CCHC domain containing 8 |
64 |
0.96 |
chr6_34176961_34177313 | 16.66 |
Slc35b4 |
solute carrier family 35, member B4 |
26 |
0.97 |
chr6_122308403_122309023 | 16.63 |
M6pr |
mannose-6-phosphate receptor, cation dependent |
7 |
0.96 |
chr3_30995329_30995526 | 16.51 |
Prkci |
protein kinase C, iota |
320 |
0.86 |
chr4_126202645_126202818 | 16.48 |
Thrap3 |
thyroid hormone receptor associated protein 3 |
29 |
0.95 |
chr14_55672094_55672446 | 16.39 |
Gmpr2 |
guanosine monophosphate reductase 2 |
12 |
0.62 |
chr7_116093028_116093395 | 16.31 |
1700003G18Rik |
RIKEN cDNA 1700003G18 gene |
52 |
0.54 |
chr13_41249637_41250153 | 16.30 |
Smim13 |
small integral membrane protein 13 |
51 |
0.96 |
chr18_65800333_65801129 | 16.19 |
Sec11c |
SEC11 homolog C, signal peptidase complex subunit |
159 |
0.93 |
chr13_112660584_112660808 | 16.15 |
Slc38a9 |
solute carrier family 38, member 9 |
55 |
0.97 |
chr15_102518263_102518974 | 16.02 |
Tarbp2 |
TARBP2, RISC loading complex RNA binding subunit |
50 |
0.94 |
chr11_69395969_69396189 | 16.02 |
Naa38 |
N(alpha)-acetyltransferase 38, NatC auxiliary subunit |
39 |
0.85 |
chr14_65833895_65834245 | 15.94 |
Esco2 |
establishment of sister chromatid cohesion N-acetyltransferase 2 |
76 |
0.97 |
chr7_25267822_25268014 | 15.87 |
Cic |
capicua transcriptional repressor |
214 |
0.85 |
chr6_3497734_3498510 | 15.85 |
Hepacam2 |
HEPACAM family member 2 |
176 |
0.61 |
chr7_28766664_28766854 | 15.84 |
Sirt2 |
sirtuin 2 |
8 |
0.6 |
chr5_138187828_138188032 | 15.72 |
Cnpy4 |
canopy FGF signaling regulator 4 |
445 |
0.37 |
chr7_27474619_27475112 | 15.70 |
Sertad3 |
SERTA domain containing 3 |
1097 |
0.29 |
chr4_56947376_56947651 | 15.63 |
Tmem245 |
transmembrane protein 245 |
76 |
0.97 |
chr6_108212919_108213199 | 15.60 |
Itpr1 |
inositol 1,4,5-trisphosphate receptor 1 |
37 |
0.98 |
chr14_56571756_56572061 | 15.53 |
Cenpj |
centromere protein J |
62 |
0.97 |
chr5_45857650_45858057 | 15.51 |
4930449I04Rik |
RIKEN cDNA 4930449I04 gene |
211 |
0.53 |
chr10_80142151_80142740 | 15.41 |
Atp5d |
ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit |
75 |
0.92 |
chr7_25237681_25238003 | 15.38 |
Gsk3a |
glycogen synthase kinase 3 alpha |
9 |
0.94 |
chr7_25238079_25238261 | 15.32 |
Gsk3a |
glycogen synthase kinase 3 alpha |
319 |
0.75 |
chr2_91183220_91183936 | 15.23 |
Madd |
MAP-kinase activating death domain |
240 |
0.86 |
chr17_56256527_56256875 | 14.91 |
Fem1a |
fem 1 homolog a |
109 |
0.92 |
chr17_47010490_47010690 | 14.83 |
Ubr2 |
ubiquitin protein ligase E3 component n-recognin 2 |
34 |
0.97 |
chr12_40222640_40222842 | 14.78 |
Gm7008 |
predicted gene 7008 |
17 |
0.46 |
chr2_145934963_145935144 | 14.68 |
Crnkl1 |
crooked neck pre-mRNA splicing factor 1 |
39 |
0.75 |
chr4_83417500_83417850 | 14.65 |
Snapc3 |
small nuclear RNA activating complex, polypeptide 3 |
49 |
0.97 |
chr5_24423517_24424454 | 14.59 |
Slc4a2 |
solute carrier family 4 (anion exchanger), member 2 |
126 |
0.78 |
chr2_69713444_69713628 | 14.55 |
Fastkd1 |
FAST kinase domains 1 |
20 |
0.96 |
chr4_116556883_116557217 | 14.55 |
Gpbp1l1 |
GC-rich promoter binding protein 1-like 1 |
608 |
0.51 |
chrX_139684844_139685709 | 14.54 |
Tbc1d8b |
TBC1 domain family, member 8B |
280 |
0.9 |
chr4_156109655_156110109 | 14.48 |
9430015G10Rik |
RIKEN cDNA 9430015G10 gene |
100 |
0.93 |
chr9_26999479_26999787 | 14.46 |
Acad8 |
acyl-Coenzyme A dehydrogenase family, member 8 |
67 |
0.5 |
chr12_91849095_91849460 | 14.44 |
Sel1l |
sel-1 suppressor of lin-12-like (C. elegans) |
120 |
0.95 |
chr15_9140259_9140542 | 14.34 |
Skp2 |
S-phase kinase-associated protein 2 (p45) |
35 |
0.65 |
chr3_30602213_30602402 | 14.32 |
Mynn |
myoneurin |
242 |
0.86 |
chr13_104178077_104178568 | 14.16 |
Trappc13 |
trafficking protein particle complex 13 |
85 |
0.51 |
chr3_85573604_85574191 | 14.05 |
Gm15535 |
predicted gene 15535 |
43 |
0.73 |
chr14_20294397_20294872 | 13.99 |
Nudt13 |
nudix (nucleoside diphosphate linked moiety X)-type motif 13 |
63 |
0.96 |
chr11_77981684_77982041 | 13.99 |
Phf12 |
PHD finger protein 12 |
892 |
0.45 |
chr9_103202051_103202227 | 13.81 |
Srprb |
signal recognition particle receptor, B subunit |
2 |
0.97 |
chr6_108064929_108065099 | 13.77 |
Setmar |
SET domain without mariner transposase fusion |
31 |
0.98 |
chr2_119208733_119209395 | 13.64 |
Zfyve19 |
zinc finger, FYVE domain containing 19 |
23 |
0.77 |
chr11_61956670_61956857 | 13.63 |
Specc1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
0 |
0.97 |
chr4_119174076_119174386 | 13.61 |
Zfp691 |
zinc finger protein 691 |
36 |
0.95 |
chr1_7397604_7397769 | 13.55 |
Gm26901 |
predicted gene, 26901 |
109 |
0.97 |
chr10_84917026_84917348 | 13.55 |
Ric8b |
RIC8 guanine nucleotide exchange factor B |
429 |
0.88 |
chr18_84951415_84951707 | 13.54 |
Timm21 |
translocase of inner mitochondrial membrane 21 |
37 |
0.91 |
chr4_48279509_48279848 | 13.53 |
Invs |
inversin |
82 |
0.55 |
chr11_116168084_116168374 | 13.41 |
Fbf1 |
Fas (TNFRSF6) binding factor 1 |
63 |
0.94 |
chr7_6283385_6284056 | 13.38 |
Gm45069 |
predicted gene 45069 |
110 |
0.93 |
chr17_56764905_56765313 | 13.37 |
Dus3l |
dihydrouridine synthase 3-like (S. cerevisiae) |
325 |
0.79 |
chr5_24394591_24394922 | 13.27 |
Abcb8 |
ATP-binding cassette, sub-family B (MDR/TAP), member 8 |
348 |
0.71 |
chr7_24608161_24608452 | 13.22 |
Phldb3 |
pleckstrin homology like domain, family B, member 3 |
2457 |
0.13 |
chr7_45062619_45062939 | 13.21 |
Prrg2 |
proline-rich Gla (G-carboxyglutamic acid) polypeptide 2 |
102 |
0.66 |
chr9_35175147_35176476 | 13.18 |
Dcps |
decapping enzyme, scavenger |
182 |
0.9 |
chr19_60890061_60890263 | 13.16 |
Grk5 |
G protein-coupled receptor kinase 5 |
233 |
0.91 |
chr9_106280906_106281086 | 13.14 |
Poc1a |
POC1 centriolar protein A |
65 |
0.96 |
chr15_44427787_44428174 | 13.14 |
Eny2 |
ENY2 transcription and export complex 2 subunit |
62 |
0.53 |
chr12_31950448_31950978 | 13.09 |
Hbp1 |
high mobility group box transcription factor 1 |
178 |
0.95 |
chr10_93453264_93453441 | 12.96 |
Lta4h |
leukotriene A4 hydrolase |
59 |
0.97 |
chr7_30169701_30169889 | 12.89 |
Zfp146 |
zinc finger protein 146 |
45 |
0.52 |
chr7_80661164_80661346 | 12.89 |
Gm15880 |
predicted gene 15880 |
25238 |
0.14 |
chr3_10440281_10440651 | 12.87 |
Snx16 |
sorting nexin 16 |
364 |
0.88 |
chr6_120038593_120038964 | 12.87 |
Wnk1 |
WNK lysine deficient protein kinase 1 |
106 |
0.96 |
chr17_46160742_46161099 | 12.86 |
Gtpbp2 |
GTP binding protein 2 |
112 |
0.93 |
chr7_16738124_16738532 | 12.81 |
Ap2s1 |
adaptor-related protein complex 2, sigma 1 subunit |
82 |
0.95 |
chr1_151754845_151755392 | 12.79 |
2810414N06Rik |
RIKEN cDNA 2810414N06 gene |
100 |
0.71 |
chr3_88552639_88553197 | 12.64 |
Lamtor2 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 |
25 |
0.91 |
chr11_35769239_35769598 | 12.62 |
Pank3 |
pantothenate kinase 3 |
66 |
0.97 |
chrX_48343022_48344334 | 12.62 |
Bcorl1 |
BCL6 co-repressor-like 1 |
92 |
0.97 |
chr13_67525535_67526312 | 12.51 |
Zfp87 |
zinc finger protein 87 |
198 |
0.51 |
chr5_148928592_148928814 | 12.51 |
Katnal1 |
katanin p60 subunit A-like 1 |
38 |
0.95 |
chr11_16950790_16951687 | 12.50 |
Eldr |
Egfr long non-coding downstream RNA |
44 |
0.62 |
chr9_56418482_56418684 | 12.49 |
Hmg20a |
high mobility group 20A |
26 |
0.9 |
chr2_29802432_29802735 | 12.47 |
Slc27a4 |
solute carrier family 27 (fatty acid transporter), member 4 |
51 |
0.95 |
chr19_45998488_45998703 | 12.43 |
Armh3 |
armadillo-like helical domain containing 3 |
107 |
0.8 |
chr16_55934785_55934961 | 12.43 |
Cep97 |
centrosomal protein 97 |
18 |
0.96 |
chr12_79172643_79173115 | 12.30 |
Vti1b |
vesicle transport through interaction with t-SNAREs 1B |
212 |
0.87 |
chr9_48479992_48480772 | 12.23 |
Rexo2 |
RNA exonuclease 2 |
197 |
0.92 |
chr7_16452653_16452993 | 12.20 |
Tmem160 |
transmembrane protein 160 |
44 |
0.95 |
chr17_23802811_23803247 | 12.18 |
Srrm2 |
serine/arginine repetitive matrix 2 |
158 |
0.85 |
chr3_90254009_90254314 | 12.14 |
Crtc2 |
CREB regulated transcription coactivator 2 |
2 |
0.94 |
chr6_72538489_72539303 | 12.12 |
Capg |
capping protein (actin filament), gelsolin-like |
5495 |
0.13 |
chr1_132417296_132418099 | 12.05 |
Dstyk |
dual serine/threonine and tyrosine protein kinase |
93 |
0.96 |
chr1_16104650_16104828 | 12.04 |
Rpl7 |
ribosomal protein L7 |
77 |
0.94 |
chr8_124721904_124722228 | 11.92 |
Arv1 |
ARV1 homolog, fatty acid homeostasis modulator |
73 |
0.5 |
chr19_46056407_46056610 | 11.89 |
Pprc1 |
peroxisome proliferative activated receptor, gamma, coactivator-related 1 |
31 |
0.96 |
chr11_30986268_30986690 | 11.87 |
Chac2 |
ChaC, cation transport regulator 2 |
129 |
0.95 |
chr13_13954280_13954635 | 11.74 |
B3galnt2 |
UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 2 |
12 |
0.95 |
chr7_43671672_43672366 | 11.74 |
Ctu1 |
cytosolic thiouridylase subunit 1 |
3 |
0.91 |
chr6_35133584_35133952 | 11.71 |
Cnot4 |
CCR4-NOT transcription complex, subunit 4 |
44 |
0.98 |
chr3_88296547_88296719 | 11.66 |
Tsacc |
TSSK6 activating co-chaperone |
205 |
0.7 |
chr8_70042925_70043096 | 11.66 |
Sugp1 |
SURP and G patch domain containing 1 |
24 |
0.78 |
chr10_119240445_119240770 | 11.63 |
Cand1 |
cullin associated and neddylation disassociated 1 |
552 |
0.79 |
chr18_80469922_80470629 | 11.62 |
Ctdp1 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 |
580 |
0.66 |
chr7_100706443_100707305 | 11.61 |
Fam168a |
family with sequence similarity 168, member A |
15 |
0.97 |
chr11_70970367_70970554 | 11.58 |
Rpain |
RPA interacting protein |
20 |
0.88 |
chr9_72985318_72986161 | 11.57 |
Ccpg1 |
cell cycle progression 1 |
120 |
0.74 |
chr11_76406626_76406991 | 11.57 |
Timm22 |
translocase of inner mitochondrial membrane 22 |
144 |
0.96 |
chr1_178187285_178187809 | 11.55 |
Desi2 |
desumoylating isopeptidase 2 |
15 |
0.98 |
chr7_131559990_131560466 | 11.52 |
Bub3 |
BUB3 mitotic checkpoint protein |
6 |
0.97 |
chr6_112696574_112696767 | 11.47 |
Rad18 |
RAD18 E3 ubiquitin protein ligase |
0 |
0.98 |
chr5_135934932_135935139 | 11.45 |
Ywhag |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide |
419 |
0.75 |
chr6_56924200_56924364 | 11.44 |
Vmn1r4 |
vomeronasal 1 receptor 4 |
260 |
0.57 |
chr5_31192582_31193365 | 11.39 |
Eif2b4 |
eukaryotic translation initiation factor 2B, subunit 4 delta |
26 |
0.75 |
chr7_80883161_80883558 | 11.35 |
Wdr73 |
WD repeat domain 73 |
17145 |
0.1 |
chr6_142756558_142756808 | 11.34 |
Cmas |
cytidine monophospho-N-acetylneuraminic acid synthetase |
3 |
0.98 |
chr6_87671761_87672474 | 11.23 |
Aplf |
aprataxin and PNKP like factor |
12 |
0.62 |
chr16_75766698_75767033 | 11.19 |
Hspa13 |
heat shock protein 70 family, member 13 |
44 |
0.97 |
chr19_6334747_6335152 | 11.18 |
Men1 |
multiple endocrine neoplasia 1 |
30 |
0.93 |
chr2_154656682_154657898 | 11.15 |
Chmp4b |
charged multivesicular body protein 4B |
272 |
0.86 |
chr8_72443687_72443997 | 11.14 |
Calr3 |
calreticulin 3 |
28 |
0.49 |
chrX_95658372_95658549 | 11.12 |
Zc4h2 |
zinc finger, C4H2 domain containing |
49 |
0.98 |
chr9_57148059_57148285 | 11.08 |
Neil1 |
nei endonuclease VIII-like 1 (E. coli) |
45 |
0.96 |
chr7_132859129_132859315 | 11.04 |
Abraxas2 |
BRISC complex subunit |
3 |
0.97 |
chr2_31688122_31688313 | 10.97 |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
159 |
0.59 |
chr11_73198991_73199166 | 10.96 |
Ctns |
cystinosis, nephropathic |
36 |
0.84 |
chr16_37540035_37540207 | 10.92 |
Rabl3 |
RAB, member RAS oncogene family-like 3 |
216 |
0.62 |
chr9_66126431_66127381 | 10.88 |
Ciao2a |
cytosolic iron-sulfur assembly component 2A |
295 |
0.5 |
chr1_106171245_106171562 | 10.84 |
Gm20753 |
predicted gene, 20753 |
121 |
0.77 |
chr15_98662857_98663041 | 10.83 |
Ddx23 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 23 |
55 |
0.95 |
chr12_31499833_31500471 | 10.83 |
Cbll1 |
Casitas B-lineage lymphoma-like 1 |
536 |
0.45 |
chr10_45577733_45577978 | 10.83 |
Hace1 |
HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1 |
26 |
0.97 |
chr16_4558583_4558771 | 10.83 |
Tfap4 |
transcription factor AP4 |
106 |
0.95 |
chr7_30551803_30552202 | 10.81 |
Hspb6 |
heat shock protein, alpha-crystallin-related, B6 |
176 |
0.53 |
chr7_4502157_4502329 | 10.80 |
Ppp1r12c |
protein phosphatase 1, regulatory subunit 12C |
563 |
0.53 |
chr6_97806779_97807061 | 10.79 |
Mitf |
melanogenesis associated transcription factor |
132 |
0.97 |
chr9_57439992_57440290 | 10.77 |
Ppcdc |
phosphopantothenoylcysteine decarboxylase |
17 |
0.96 |
chr19_37207415_37207878 | 10.73 |
Marchf5 |
membrane associated ring-CH-type finger 5 |
70 |
0.59 |
chr12_76962201_76962838 | 10.68 |
Max |
Max protein |
318 |
0.88 |
chr8_3516721_3517290 | 10.68 |
Pnpla6 |
patatin-like phospholipase domain containing 6 |
131 |
0.92 |
chr7_101663204_101664247 | 10.67 |
Clpb |
ClpB caseinolytic peptidase B |
20 |
0.98 |
chr16_84835264_84835445 | 10.60 |
Atp5j |
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F |
56 |
0.73 |
chr6_67266686_67267030 | 10.60 |
Serbp1 |
serpine1 mRNA binding protein 1 |
125 |
0.95 |
chr1_128102701_128102870 | 10.58 |
Zranb3 |
zinc finger, RAN-binding domain containing 3 |
216 |
0.71 |
chr3_37532147_37532353 | 10.49 |
Gm12564 |
predicted gene 12564 |
24253 |
0.12 |
chr4_44756160_44756336 | 10.48 |
Zcchc7 |
zinc finger, CCHC domain containing 7 |
320 |
0.86 |
chr7_3629582_3629744 | 10.48 |
Tfpt |
TCF3 (E2A) fusion partner |
84 |
0.75 |
chr11_4703830_4704424 | 10.43 |
Uqcr10 |
ubiquinol-cytochrome c reductase, complex III subunit X |
74 |
0.89 |
chr16_16358774_16359383 | 10.40 |
Dnm1l |
dynamin 1-like |
119 |
0.94 |
chr5_24576849_24578099 | 10.36 |
Abcf2 |
ATP-binding cassette, sub-family F (GCN20), member 2 |
7 |
0.95 |
chr3_97158634_97158816 | 10.34 |
Acp6 |
acid phosphatase 6, lysophosphatidic |
52 |
0.97 |
chr14_79426283_79426783 | 10.34 |
Kbtbd7 |
kelch repeat and BTB (POZ) domain containing 7 |
22 |
0.97 |
chr13_86046709_86047010 | 10.27 |
Cox7c |
cytochrome c oxidase subunit 7C |
45 |
0.98 |
chr13_54589583_54590274 | 10.19 |
Nop16 |
NOP16 nucleolar protein |
48 |
0.77 |
chr19_34550534_34550731 | 10.15 |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
62 |
0.94 |
chr8_117480584_117480735 | 10.15 |
Plcg2 |
phospholipase C, gamma 2 |
17632 |
0.15 |
chr5_21056376_21056547 | 10.14 |
Ptpn12 |
protein tyrosine phosphatase, non-receptor type 12 |
550 |
0.73 |
chr8_57487516_57488009 | 10.08 |
Sap30 |
sin3 associated polypeptide |
98 |
0.74 |
chr17_25875380_25875576 | 10.08 |
Mettl26 |
methyltransferase like 26 |
14 |
0.92 |
chr12_8640731_8640909 | 10.06 |
Pum2 |
pumilio RNA-binding family member 2 |
33314 |
0.16 |
chr8_110919614_110920505 | 10.06 |
St3gal2 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
101 |
0.94 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.7 | 29.2 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
7.0 | 27.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
6.9 | 20.7 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
6.8 | 20.5 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
6.0 | 42.0 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
5.7 | 17.0 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
5.5 | 22.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
5.5 | 21.8 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
5.4 | 21.5 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
5.2 | 15.7 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
5.2 | 15.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
4.5 | 13.4 | GO:0036394 | amylase secretion(GO:0036394) |
4.3 | 21.3 | GO:0090148 | membrane fission(GO:0090148) |
4.1 | 20.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
4.1 | 12.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
4.1 | 4.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
3.9 | 23.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
3.6 | 10.7 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
3.5 | 17.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
3.5 | 10.6 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
3.4 | 33.8 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
3.3 | 9.9 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
3.3 | 19.7 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
3.3 | 16.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
3.2 | 13.0 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
3.2 | 16.2 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
3.2 | 9.5 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
3.1 | 12.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
3.0 | 9.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
3.0 | 9.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
3.0 | 5.9 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
2.9 | 29.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
2.9 | 8.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
2.9 | 11.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
2.9 | 11.5 | GO:0009838 | abscission(GO:0009838) |
2.9 | 25.9 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
2.9 | 8.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
2.8 | 11.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
2.8 | 11.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
2.8 | 19.5 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
2.8 | 8.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
2.7 | 13.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
2.7 | 5.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
2.7 | 18.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
2.6 | 18.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
2.5 | 12.6 | GO:0051013 | microtubule severing(GO:0051013) |
2.5 | 7.4 | GO:0030242 | pexophagy(GO:0030242) |
2.5 | 24.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
2.4 | 2.4 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
2.4 | 7.2 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
2.4 | 7.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
2.4 | 7.2 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
2.4 | 12.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
2.4 | 7.2 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
2.4 | 11.9 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
2.4 | 19.0 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.3 | 21.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
2.3 | 9.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
2.3 | 6.8 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
2.3 | 18.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
2.2 | 9.0 | GO:0051697 | protein delipidation(GO:0051697) |
2.2 | 22.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
2.2 | 13.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
2.2 | 24.0 | GO:0042407 | cristae formation(GO:0042407) |
2.2 | 6.5 | GO:0044845 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
2.2 | 6.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
2.2 | 6.5 | GO:0000087 | mitotic M phase(GO:0000087) |
2.2 | 10.8 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
2.1 | 10.6 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
2.1 | 16.9 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
2.1 | 6.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
2.1 | 4.2 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
2.1 | 4.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
2.1 | 8.3 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
2.1 | 12.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
2.1 | 14.4 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
2.0 | 10.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
2.0 | 2.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
2.0 | 6.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
2.0 | 4.0 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
2.0 | 8.0 | GO:0048478 | replication fork protection(GO:0048478) |
2.0 | 9.9 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.9 | 5.8 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
1.9 | 7.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.9 | 9.4 | GO:0009642 | response to light intensity(GO:0009642) |
1.9 | 5.6 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
1.9 | 7.5 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
1.9 | 14.9 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
1.8 | 9.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.8 | 1.8 | GO:0016573 | histone acetylation(GO:0016573) |
1.8 | 5.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
1.8 | 7.3 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
1.8 | 5.4 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
1.8 | 7.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
1.8 | 5.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.8 | 7.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
1.8 | 3.5 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
1.8 | 8.8 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
1.7 | 3.5 | GO:0036507 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
1.7 | 5.2 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
1.7 | 5.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.7 | 8.4 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
1.7 | 3.4 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
1.7 | 24.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
1.7 | 19.9 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
1.7 | 6.6 | GO:0051031 | tRNA transport(GO:0051031) |
1.6 | 6.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
1.6 | 6.6 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.6 | 4.9 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.6 | 4.9 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
1.6 | 4.8 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
1.6 | 9.5 | GO:0007000 | nucleolus organization(GO:0007000) |
1.6 | 9.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.6 | 4.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
1.6 | 9.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.5 | 6.2 | GO:0035826 | rubidium ion transport(GO:0035826) |
1.5 | 6.1 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
1.5 | 10.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.5 | 4.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.5 | 12.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
1.5 | 4.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.5 | 4.5 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.5 | 3.0 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
1.5 | 10.4 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
1.5 | 20.7 | GO:0006465 | signal peptide processing(GO:0006465) |
1.5 | 7.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
1.5 | 4.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.5 | 1.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.5 | 8.8 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
1.5 | 11.7 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
1.5 | 1.5 | GO:0061010 | gall bladder development(GO:0061010) |
1.4 | 4.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
1.4 | 1.4 | GO:0040031 | snRNA modification(GO:0040031) |
1.4 | 5.8 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.4 | 1.4 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
1.4 | 11.3 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
1.4 | 4.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.4 | 1.4 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
1.4 | 1.4 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
1.4 | 7.0 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
1.4 | 4.2 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
1.4 | 2.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
1.4 | 13.8 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
1.4 | 10.9 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
1.4 | 12.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
1.4 | 8.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
1.4 | 4.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.3 | 10.8 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
1.3 | 2.7 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
1.3 | 5.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.3 | 4.0 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
1.3 | 6.6 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.3 | 6.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.3 | 25.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
1.3 | 32.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
1.3 | 1.3 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.3 | 5.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
1.3 | 13.9 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
1.3 | 32.7 | GO:0031648 | protein destabilization(GO:0031648) |
1.3 | 5.0 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.2 | 9.9 | GO:0043248 | proteasome assembly(GO:0043248) |
1.2 | 12.3 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
1.2 | 21.8 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
1.2 | 8.4 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
1.2 | 6.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
1.2 | 4.8 | GO:0006742 | NADP catabolic process(GO:0006742) |
1.2 | 15.2 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
1.2 | 3.5 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
1.2 | 12.8 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
1.2 | 4.6 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
1.2 | 18.5 | GO:0016180 | snRNA processing(GO:0016180) |
1.2 | 6.9 | GO:0015884 | folic acid transport(GO:0015884) |
1.1 | 6.8 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
1.1 | 4.5 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
1.1 | 11.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
1.1 | 19.8 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
1.1 | 12.1 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
1.1 | 3.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.1 | 17.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
1.1 | 13.1 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
1.1 | 5.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
1.1 | 5.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
1.1 | 2.2 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
1.1 | 14.1 | GO:0045116 | protein neddylation(GO:0045116) |
1.1 | 1.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.1 | 14.8 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
1.0 | 2.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
1.0 | 1.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
1.0 | 12.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
1.0 | 10.2 | GO:0032365 | intracellular lipid transport(GO:0032365) |
1.0 | 4.1 | GO:0018343 | protein farnesylation(GO:0018343) |
1.0 | 3.0 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
1.0 | 6.0 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
1.0 | 16.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
1.0 | 16.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
1.0 | 4.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
1.0 | 2.0 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.0 | 5.9 | GO:0016078 | tRNA catabolic process(GO:0016078) |
1.0 | 3.0 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
1.0 | 3.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.0 | 3.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
1.0 | 2.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
1.0 | 14.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
1.0 | 2.9 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.0 | 6.8 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
1.0 | 2.9 | GO:0072718 | response to cisplatin(GO:0072718) |
1.0 | 1.9 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.9 | 5.6 | GO:1902222 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.9 | 3.6 | GO:0046931 | pore complex assembly(GO:0046931) |
0.9 | 7.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.9 | 5.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.9 | 6.3 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.9 | 2.7 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.9 | 10.7 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.9 | 8.8 | GO:0016556 | mRNA modification(GO:0016556) |
0.9 | 6.1 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.9 | 30.2 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.9 | 2.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.9 | 1.7 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.8 | 3.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.8 | 2.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.8 | 0.8 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.8 | 7.5 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.8 | 8.3 | GO:0031297 | replication fork processing(GO:0031297) |
0.8 | 8.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.8 | 0.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.8 | 2.5 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.8 | 1.6 | GO:0002432 | granuloma formation(GO:0002432) |
0.8 | 1.6 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.8 | 8.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.8 | 5.6 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.8 | 0.8 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.8 | 2.4 | GO:1904292 | regulation of ERAD pathway(GO:1904292) positive regulation of ERAD pathway(GO:1904294) |
0.8 | 8.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.8 | 7.8 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.8 | 18.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.8 | 9.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.8 | 3.9 | GO:0002576 | platelet degranulation(GO:0002576) |
0.8 | 1.6 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.8 | 2.3 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.8 | 13.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.8 | 3.8 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.8 | 2.3 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.8 | 6.8 | GO:0000154 | rRNA modification(GO:0000154) |
0.8 | 0.8 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.8 | 1.5 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.8 | 2.3 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.7 | 2.2 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.7 | 0.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.7 | 1.5 | GO:1903430 | negative regulation of neuron maturation(GO:0014043) negative regulation of cell maturation(GO:1903430) |
0.7 | 63.8 | GO:0008033 | tRNA processing(GO:0008033) |
0.7 | 2.2 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.7 | 3.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.7 | 2.9 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.7 | 5.8 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.7 | 6.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.7 | 0.7 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.7 | 5.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.7 | 1.4 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.7 | 2.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.7 | 1.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.7 | 1.4 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.7 | 7.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.7 | 1.4 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.7 | 2.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.7 | 2.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.7 | 2.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.7 | 2.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.7 | 1.4 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.7 | 4.8 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.7 | 2.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.7 | 4.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.7 | 6.8 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.7 | 1.4 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.7 | 1.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.7 | 1.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.7 | 1.3 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.7 | 3.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.7 | 6.0 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.7 | 3.3 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.7 | 3.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.7 | 0.7 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.7 | 4.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.7 | 2.0 | GO:0035928 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.7 | 0.7 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.6 | 22.1 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.6 | 1.3 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.6 | 6.5 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.6 | 1.9 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.6 | 3.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 15.4 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.6 | 11.5 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.6 | 1.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.6 | 1.9 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.6 | 3.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.6 | 0.6 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.6 | 1.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.6 | 24.7 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.6 | 0.6 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.6 | 13.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.6 | 4.4 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.6 | 1.9 | GO:0042938 | dipeptide transport(GO:0042938) |
0.6 | 5.6 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.6 | 4.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.6 | 6.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.6 | 1.9 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.6 | 1.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.6 | 6.2 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.6 | 1.8 | GO:0008228 | opsonization(GO:0008228) |
0.6 | 3.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.6 | 12.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.6 | 4.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.6 | 9.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.6 | 2.4 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.6 | 3.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.6 | 3.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.6 | 42.9 | GO:0051297 | centrosome organization(GO:0051297) |
0.6 | 1.8 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.6 | 121.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.6 | 42.7 | GO:0007030 | Golgi organization(GO:0007030) |
0.6 | 8.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.6 | 0.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.6 | 2.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.6 | 1.2 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.6 | 30.9 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.6 | 5.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.6 | 4.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.6 | 8.7 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.6 | 24.9 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.6 | 1.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.6 | 0.6 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.6 | 7.4 | GO:0006301 | postreplication repair(GO:0006301) |
0.6 | 5.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.6 | 1.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.6 | 1.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.6 | 0.6 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.6 | 1.1 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.6 | 0.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.6 | 1.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.6 | 1.7 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.6 | 1.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.5 | 1.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.5 | 1.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.5 | 1.1 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.5 | 0.5 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.5 | 11.9 | GO:0034605 | cellular response to heat(GO:0034605) |
0.5 | 3.2 | GO:0015074 | DNA integration(GO:0015074) |
0.5 | 5.4 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.5 | 1.1 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.5 | 9.1 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.5 | 2.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.5 | 1.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.5 | 3.2 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) negative regulation of TORC1 signaling(GO:1904262) |
0.5 | 2.7 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.5 | 1.1 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.5 | 2.7 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.5 | 1.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.5 | 6.9 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.5 | 1.6 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.5 | 1.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.5 | 0.5 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
0.5 | 1.1 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.5 | 1.0 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.5 | 2.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.5 | 2.1 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.5 | 1.0 | GO:1904754 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.5 | 1.6 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.5 | 1.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.5 | 1.0 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.5 | 3.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.5 | 5.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.5 | 16.0 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.5 | 1.0 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.5 | 1.5 | GO:0009139 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.5 | 7.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.5 | 1.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.5 | 1.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.5 | 1.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.5 | 5.0 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.5 | 9.5 | GO:0017145 | stem cell division(GO:0017145) |
0.5 | 2.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.5 | 2.5 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.5 | 1.0 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.5 | 3.9 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.5 | 2.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.5 | 1.5 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.5 | 2.5 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.5 | 2.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.5 | 1.0 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.5 | 3.4 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.5 | 1.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 0.5 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.5 | 2.9 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.5 | 2.4 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.5 | 1.9 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.5 | 0.5 | GO:0006473 | protein acetylation(GO:0006473) |
0.5 | 1.9 | GO:0015886 | heme transport(GO:0015886) |
0.5 | 20.8 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.5 | 3.3 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.5 | 0.9 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.5 | 1.4 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.5 | 0.5 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.5 | 0.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.5 | 3.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.5 | 1.9 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.5 | 13.0 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.5 | 15.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.5 | 0.5 | GO:1903416 | response to glycoside(GO:1903416) |
0.5 | 1.8 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.5 | 2.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.5 | 2.3 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.5 | 0.5 | GO:0019086 | late viral transcription(GO:0019086) |
0.5 | 2.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.5 | 2.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 0.9 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.4 | 0.4 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.4 | 1.3 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.4 | 4.0 | GO:0010165 | response to X-ray(GO:0010165) |
0.4 | 2.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.4 | 0.9 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.4 | 0.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.4 | 3.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.4 | 10.7 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.4 | 0.8 | GO:1903972 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.4 | 0.8 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.4 | 2.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.4 | 2.9 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.4 | 0.4 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.4 | 2.1 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 4.2 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.4 | 1.7 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 7.9 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.4 | 0.4 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
0.4 | 1.6 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.4 | 1.6 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.4 | 2.5 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.4 | 2.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.4 | 2.4 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.4 | 0.8 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.4 | 2.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.4 | 1.6 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.4 | 0.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.4 | 1.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.4 | 1.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.4 | 1.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.4 | 1.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 2.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.4 | 1.2 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.4 | 0.8 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.4 | 0.4 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.4 | 1.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.4 | 0.4 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.4 | 14.1 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.4 | 1.5 | GO:2000774 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.4 | 1.9 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.4 | 0.8 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.4 | 1.1 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.4 | 2.6 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.4 | 0.8 | GO:0030576 | Cajal body organization(GO:0030576) |
0.4 | 0.4 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.4 | 0.7 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.4 | 5.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.4 | 0.4 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.4 | 1.1 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.4 | 21.3 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.4 | 2.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.4 | 3.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.4 | 1.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.4 | 1.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.4 | 1.5 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.4 | 0.4 | GO:0060558 | regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.4 | 0.7 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 1.8 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.4 | 0.7 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.4 | 0.7 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.4 | 3.5 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.4 | 11.0 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.4 | 1.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.4 | 5.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.4 | 3.5 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.3 | 7.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.3 | 1.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 0.7 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.3 | 1.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.3 | 2.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.3 | 16.6 | GO:0034968 | histone lysine methylation(GO:0034968) |
0.3 | 5.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.3 | 1.4 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.3 | 0.3 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.3 | 15.0 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
0.3 | 3.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.3 | 0.7 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 0.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 0.7 | GO:0051383 | kinetochore organization(GO:0051383) |
0.3 | 1.0 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.3 | 0.7 | GO:0097460 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
0.3 | 0.7 | GO:0001302 | replicative cell aging(GO:0001302) |
0.3 | 4.4 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
0.3 | 1.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.3 | 0.3 | GO:0072553 | terminal button organization(GO:0072553) |
0.3 | 6.0 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.3 | 1.0 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.3 | 0.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.3 | 4.6 | GO:0042168 | heme metabolic process(GO:0042168) |
0.3 | 1.0 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 2.3 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.3 | 9.6 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.3 | 0.7 | GO:0030878 | thyroid gland development(GO:0030878) |
0.3 | 16.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.3 | 1.0 | GO:0030070 | insulin processing(GO:0030070) |
0.3 | 1.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.3 | 0.3 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.3 | 9.5 | GO:0042073 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.3 | 0.3 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.3 | 0.7 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.3 | 0.3 | GO:0098586 | cellular response to virus(GO:0098586) |
0.3 | 3.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.3 | 2.6 | GO:0046036 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.3 | 0.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.3 | 6.7 | GO:0007602 | phototransduction(GO:0007602) |
0.3 | 1.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.3 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 12.7 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.3 | 0.3 | GO:0060374 | mast cell differentiation(GO:0060374) |
0.3 | 0.3 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.3 | 1.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 11.6 | GO:0009411 | response to UV(GO:0009411) |
0.3 | 0.9 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 0.6 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.3 | 0.6 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.3 | 0.9 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.3 | 1.9 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.3 | 0.3 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.3 | 6.2 | GO:0010043 | response to zinc ion(GO:0010043) |
0.3 | 0.9 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.3 | 0.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 0.6 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.3 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 1.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.3 | 6.7 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.3 | 8.8 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.3 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.3 | 0.3 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.3 | 0.6 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 1.5 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.3 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.3 | 5.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 3.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 0.3 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.3 | 0.6 | GO:0007569 | cell aging(GO:0007569) |
0.3 | 2.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.3 | 1.2 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.3 | 2.1 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 1.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.3 | 0.3 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.3 | 1.5 | GO:0015879 | carnitine transport(GO:0015879) |
0.3 | 2.0 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.3 | 4.1 | GO:0048821 | erythrocyte development(GO:0048821) |
0.3 | 1.2 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.3 | 1.2 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.3 | 0.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.3 | 0.6 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 4.6 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.3 | 0.9 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.3 | 1.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 0.6 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.3 | 0.3 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.3 | 0.6 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.3 | 0.8 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.3 | 1.4 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.3 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.3 | 0.3 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) |
0.3 | 7.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.3 | 8.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.3 | 0.8 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.3 | 20.0 | GO:0045333 | cellular respiration(GO:0045333) |
0.3 | 1.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.3 | 0.8 | GO:0007619 | courtship behavior(GO:0007619) |
0.3 | 1.1 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.3 | 0.3 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 0.8 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.3 | 6.7 | GO:0048286 | lung alveolus development(GO:0048286) |
0.3 | 0.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 0.5 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.3 | 0.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 0.3 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.3 | 0.5 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.3 | 0.5 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.3 | 9.8 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.3 | 0.3 | GO:0015744 | succinate transport(GO:0015744) |
0.3 | 0.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 0.3 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.3 | 0.5 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.3 | 0.3 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.3 | 1.5 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.3 | 0.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.3 | 0.3 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.3 | 0.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 1.8 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 0.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.2 | 0.2 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 1.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 1.2 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.2 | 3.7 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.2 | 0.5 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.2 | 4.4 | GO:1901998 | toxin transport(GO:1901998) |
0.2 | 0.2 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.2 | 3.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 0.5 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.2 | 0.2 | GO:0010536 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 1.7 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.2 | 2.9 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.2 | 0.5 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.2 | 0.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.5 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.2 | 0.2 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.2 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 0.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.2 | 0.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 0.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.2 | 0.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 0.7 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 1.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 1.2 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.2 | 0.2 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.2 | 5.1 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.2 | 1.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 1.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.2 | 0.7 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.2 | 1.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 0.9 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 0.9 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 0.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 7.9 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.2 | 0.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.2 | 0.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 0.7 | GO:1902893 | regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902893) |
0.2 | 0.2 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.2 | 0.2 | GO:2000644 | regulation of receptor catabolic process(GO:2000644) negative regulation of receptor catabolic process(GO:2000645) |
0.2 | 0.7 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.2 | 0.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.2 | 0.4 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.2 | 1.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 3.3 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.2 | 0.7 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.2 | 0.9 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.2 | 0.7 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.2 | 4.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 0.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 7.2 | GO:0030518 | intracellular steroid hormone receptor signaling pathway(GO:0030518) |
0.2 | 2.8 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 0.7 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.2 | 2.6 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.2 | 4.6 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.2 | 0.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 1.7 | GO:0051168 | nuclear export(GO:0051168) |
0.2 | 0.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 0.9 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.2 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.2 | 0.6 | GO:0002673 | regulation of acute inflammatory response(GO:0002673) |
0.2 | 7.6 | GO:0006364 | rRNA processing(GO:0006364) |
0.2 | 3.6 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 1.1 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.2 | 5.5 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.2 | 1.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 0.4 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.2 | 0.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 0.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 1.0 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.2 | 0.8 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.2 | 0.8 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.6 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.2 | 0.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 1.4 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.2 | 0.8 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 2.2 | GO:0010498 | proteasomal protein catabolic process(GO:0010498) |
0.2 | 0.2 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) |
0.2 | 0.2 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.2 | 0.4 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.2 | 0.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 1.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 0.4 | GO:0003170 | heart valve development(GO:0003170) |
0.2 | 0.4 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.2 | 0.8 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.2 | 1.0 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.6 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.2 | 0.4 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 0.2 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.2 | 0.6 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 1.9 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 3.9 | GO:0016925 | protein sumoylation(GO:0016925) |
0.2 | 0.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.2 | 0.4 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.2 | 1.0 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.2 | 0.2 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) |
0.2 | 2.8 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 0.2 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.2 | 0.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 | 1.1 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.2 | 0.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 2.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 1.3 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.2 | 0.7 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 3.1 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 1.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 0.4 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.2 | 1.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.7 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.2 | 0.4 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 0.4 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.2 | 0.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 0.4 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.2 | 0.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 0.5 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 1.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 1.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 1.4 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.2 | 5.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 0.4 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.2 | 0.4 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.2 | 0.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 0.2 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.2 | 1.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 1.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.3 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.5 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 0.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 0.3 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 0.3 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 0.2 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.2 | 1.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.9 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.2 | 0.5 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 1.9 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.2 | 0.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.2 | 1.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 1.2 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.2 | 7.0 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.2 | 0.2 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.2 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.2 | 0.3 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.2 | 0.2 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.2 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 1.0 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.2 | 1.0 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.2 | 0.2 | GO:0097320 | membrane tubulation(GO:0097320) |
0.2 | 0.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.2 | 1.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 49.4 | GO:0006412 | translation(GO:0006412) |
0.2 | 0.3 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.2 | 0.5 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.2 | 0.2 | GO:0052204 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) |
0.2 | 0.5 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.2 | 3.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.2 | 2.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 1.1 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.2 | 0.6 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.2 | 0.3 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.2 | 0.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.6 | GO:0061515 | myeloid cell development(GO:0061515) |
0.2 | 6.5 | GO:0006310 | DNA recombination(GO:0006310) |
0.2 | 0.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.2 | 0.3 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.2 | 4.6 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 0.3 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 0.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 0.2 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 1.1 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.2 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 7.3 | GO:0032869 | cellular response to insulin stimulus(GO:0032869) |
0.2 | 0.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.2 | GO:0016441 | posttranscriptional gene silencing(GO:0016441) |
0.2 | 0.2 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.2 | 0.5 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.2 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.2 | 1.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.8 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 0.2 | GO:1902001 | plasma membrane long-chain fatty acid transport(GO:0015911) fatty acid transmembrane transport(GO:1902001) |
0.2 | 0.2 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.2 | 3.9 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.2 | 0.3 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.4 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 1.9 | GO:0046464 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.1 | 1.1 | GO:0060479 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.1 | 0.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.1 | GO:0060896 | neural plate pattern specification(GO:0060896) |
0.1 | 0.1 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.1 | 0.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.6 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.3 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.6 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 2.0 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 0.1 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.3 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.1 | 0.4 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.1 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.1 | 0.4 | GO:1903573 | negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
0.1 | 0.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.1 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.1 | 0.3 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 1.4 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.1 | 0.3 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 0.3 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.1 | 2.6 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 11.2 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.1 | 0.3 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.3 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 1.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 1.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 3.4 | GO:0006606 | protein import into nucleus(GO:0006606) protein targeting to nucleus(GO:0044744) single-organism nuclear import(GO:1902593) |
0.1 | 0.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.1 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.1 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.1 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.1 | 1.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.8 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 1.7 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.3 | GO:0001794 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.1 | 1.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 1.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 2.6 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 0.8 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 1.0 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.4 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.3 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 0.6 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.4 | GO:0003093 | regulation of glomerular filtration(GO:0003093) negative regulation of glomerular filtration(GO:0003105) |
0.1 | 0.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.2 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.1 | 0.1 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.4 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.6 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.1 | 0.5 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 0.5 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.1 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.1 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.1 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.1 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.1 | 0.1 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.1 | 1.7 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.5 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.1 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.1 | 3.4 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 0.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.4 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.4 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 1.0 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.5 | GO:2000756 | regulation of peptidyl-lysine acetylation(GO:2000756) |
0.1 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.1 | GO:0044557 | relaxation of smooth muscle(GO:0044557) relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.6 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 2.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 19.6 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.1 | 0.9 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.1 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 1.1 | GO:0006818 | hydrogen transport(GO:0006818) |
0.1 | 1.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 26.4 | GO:0048232 | male gamete generation(GO:0048232) |
0.1 | 2.8 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.1 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 4.3 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.1 | 1.8 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
0.1 | 1.2 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.1 | 0.2 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.1 | 0.1 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.4 | GO:0032095 | regulation of response to food(GO:0032095) |
0.1 | 0.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.1 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
0.1 | 0.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.7 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.1 | 0.4 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.4 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.1 | 0.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.2 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 0.1 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.1 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.1 | 1.4 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 1.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.3 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.1 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.1 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.5 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.2 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.1 | 0.3 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.4 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.4 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.1 | 0.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.1 | GO:0051342 | protein maturation by protein folding(GO:0022417) regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.1 | 0.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.2 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.2 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 5.6 | GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity(GO:0051091) |
0.1 | 0.1 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.1 | 0.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.2 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.3 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.7 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.1 | GO:0044257 | cellular protein catabolic process(GO:0044257) |
0.1 | 0.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.2 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.1 | 0.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 2.4 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 1.6 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 3.8 | GO:0046328 | regulation of JNK cascade(GO:0046328) |
0.1 | 0.1 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.1 | 0.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 0.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.7 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.1 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) |
0.1 | 3.5 | GO:0098792 | xenophagy(GO:0098792) |
0.1 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.1 | GO:0032530 | regulation of microvillus organization(GO:0032530) regulation of microvillus assembly(GO:0032534) |
0.1 | 2.3 | GO:0060348 | bone development(GO:0060348) |
0.1 | 0.3 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 0.2 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.1 | 0.3 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 1.0 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.1 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 0.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.2 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.6 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 7.6 | GO:0006814 | sodium ion transport(GO:0006814) |
0.1 | 0.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.3 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.5 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.1 | 0.1 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
0.1 | 0.1 | GO:0006476 | protein deacetylation(GO:0006476) |
0.1 | 0.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.1 | GO:0001914 | regulation of T cell mediated cytotoxicity(GO:0001914) |
0.1 | 0.2 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 4.5 | GO:0044782 | cilium organization(GO:0044782) |
0.1 | 0.2 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.1 | 0.3 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.2 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.6 | GO:0000302 | response to reactive oxygen species(GO:0000302) |
0.1 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.5 | GO:0034599 | cellular response to oxidative stress(GO:0034599) |
0.1 | 0.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 11.0 | GO:0007017 | microtubule-based process(GO:0007017) |
0.1 | 10.1 | GO:0043066 | negative regulation of apoptotic process(GO:0043066) |
0.1 | 0.2 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.1 | 0.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.4 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 0.3 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.7 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.1 | GO:0019230 | proprioception(GO:0019230) |
0.1 | 3.4 | GO:0033674 | positive regulation of kinase activity(GO:0033674) |
0.1 | 0.5 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.1 | 0.1 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.1 | 0.1 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.1 | 2.0 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.2 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.2 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 100.8 | GO:0006355 | regulation of transcription, DNA-templated(GO:0006355) |
0.1 | 0.1 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.1 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.1 | 0.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.1 | GO:0034248 | regulation of cellular amide metabolic process(GO:0034248) |
0.1 | 0.1 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.1 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
0.1 | 0.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.3 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.1 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.1 | 0.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.2 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.1 | GO:0071220 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
0.1 | 0.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 1.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.4 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 7.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 1.2 | GO:0001666 | response to hypoxia(GO:0001666) |
0.1 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.1 | 0.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.3 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.2 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.8 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.1 | 0.1 | GO:2000648 | positive regulation of stem cell proliferation(GO:2000648) |
0.1 | 0.1 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 3.7 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 1.9 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.1 | 0.1 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.1 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.1 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.1 | 0.2 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.2 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
0.1 | 0.5 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.1 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.1 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.7 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 0.2 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.8 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.1 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.1 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.2 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.1 | GO:0019478 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) D-amino acid catabolic process(GO:0019478) |
0.1 | 0.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.1 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.1 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.8 | GO:0030324 | lung development(GO:0030324) |
0.1 | 0.4 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.1 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.1 | 0.2 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.5 | GO:0005977 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 0.2 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.1 | 0.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.1 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.1 | 3.6 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.1 | 0.3 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 2.1 | GO:0007005 | mitochondrion organization(GO:0007005) |
0.1 | 0.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.0 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.0 | 0.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.0 | 0.0 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
0.0 | 0.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.1 | GO:0006304 | DNA modification(GO:0006304) |
0.0 | 0.0 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.0 | 0.0 | GO:0009218 | pyrimidine ribonucleotide metabolic process(GO:0009218) |
0.0 | 0.1 | GO:0051591 | response to cAMP(GO:0051591) |
0.0 | 0.0 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.5 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.7 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.0 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.0 | 0.0 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.4 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 1.7 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.0 | 0.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.4 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.3 | GO:0002262 | myeloid cell homeostasis(GO:0002262) |
0.0 | 0.1 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.0 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:0097205 | renal filtration(GO:0097205) |
0.0 | 0.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.0 | 0.2 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.3 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.0 | 0.0 | GO:0009583 | detection of light stimulus(GO:0009583) |
0.0 | 1.2 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.0 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.1 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 1.9 | GO:0032259 | methylation(GO:0032259) |
0.0 | 0.0 | GO:0050779 | RNA destabilization(GO:0050779) |
0.0 | 0.1 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.0 | 0.0 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.0 | 0.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.0 | 0.1 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.0 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.4 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.1 | GO:0000096 | sulfur amino acid metabolic process(GO:0000096) |
0.0 | 0.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.1 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.0 | 0.1 | GO:1901215 | negative regulation of neuron death(GO:1901215) |
0.0 | 0.5 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.0 | 0.0 | GO:0044838 | cell quiescence(GO:0044838) |
0.0 | 0.0 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.0 | 0.0 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.0 | 0.2 | GO:0050821 | protein stabilization(GO:0050821) |
0.0 | 0.0 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.0 | 0.0 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.0 | 0.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.2 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.9 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 3.4 | GO:0006954 | inflammatory response(GO:0006954) |
0.0 | 0.0 | GO:0070167 | regulation of biomineral tissue development(GO:0070167) |
0.0 | 0.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.0 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.0 | 0.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.0 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.0 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.5 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.0 | 0.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 4.5 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.0 | 0.0 | GO:0032655 | regulation of interleukin-12 production(GO:0032655) |
0.0 | 0.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.0 | GO:0043094 | cellular metabolic compound salvage(GO:0043094) |
0.0 | 0.1 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.1 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 0.1 | GO:0002704 | negative regulation of leukocyte mediated immunity(GO:0002704) |
0.0 | 0.0 | GO:0044033 | multi-organism metabolic process(GO:0044033) |
0.0 | 0.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.0 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.0 | GO:0002931 | response to ischemia(GO:0002931) |
0.0 | 0.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.0 | GO:0034698 | response to gonadotropin(GO:0034698) cellular response to gonadotropin stimulus(GO:0071371) |
0.0 | 0.1 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) |
0.0 | 0.0 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.1 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.0 | GO:0050701 | interleukin-1 secretion(GO:0050701) |
0.0 | 0.0 | GO:0035794 | positive regulation of mitochondrial membrane permeability(GO:0035794) |
0.0 | 0.2 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.0 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.0 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.0 | 0.0 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.0 | 0.1 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.1 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.1 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.0 | 0.0 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.0 | 0.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.1 | GO:0048066 | developmental pigmentation(GO:0048066) |
0.0 | 0.0 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.0 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.0 | 0.0 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.0 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.0 | 0.1 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) protein deglutamylation(GO:0035608) |
0.0 | 0.1 | GO:0031103 | axon regeneration(GO:0031103) |
0.0 | 0.0 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.0 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.0 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.0 | GO:0014856 | skeletal muscle satellite cell differentiation(GO:0014816) skeletal muscle satellite cell proliferation(GO:0014841) skeletal muscle cell proliferation(GO:0014856) |
0.0 | 0.0 | GO:0060788 | ectodermal placode formation(GO:0060788) ectodermal placode development(GO:0071696) ectodermal placode morphogenesis(GO:0071697) |
0.0 | 0.1 | GO:0045580 | regulation of T cell differentiation(GO:0045580) |
0.0 | 0.1 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.0 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.0 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.0 | 0.0 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.0 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.0 | GO:0043299 | leukocyte degranulation(GO:0043299) |
0.0 | 0.0 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.0 | GO:2001242 | regulation of intrinsic apoptotic signaling pathway(GO:2001242) |
0.0 | 1.3 | GO:0006886 | intracellular protein transport(GO:0006886) |
0.0 | 0.1 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.2 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.0 | 0.0 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.0 | 0.0 | GO:0001994 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.0 | 0.0 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.0 | 0.0 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.0 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.0 | 0.0 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.0 | 0.0 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
0.0 | 0.0 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 0.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.0 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
0.0 | 0.1 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.0 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.0 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.0 | GO:0046543 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
0.0 | 0.0 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.0 | 0.2 | GO:0051253 | negative regulation of RNA metabolic process(GO:0051253) |
0.0 | 0.1 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.0 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.0 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 21.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
6.9 | 20.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
5.4 | 16.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
5.1 | 15.3 | GO:0031417 | NatC complex(GO:0031417) |
5.0 | 29.8 | GO:0071986 | Ragulator complex(GO:0071986) |
4.5 | 18.0 | GO:0070545 | PeBoW complex(GO:0070545) |
4.4 | 4.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
4.2 | 16.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
3.6 | 10.8 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
3.5 | 35.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
3.5 | 24.4 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
3.2 | 12.7 | GO:0030689 | Noc complex(GO:0030689) |
3.1 | 15.6 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
3.1 | 12.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
3.0 | 9.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
2.9 | 14.5 | GO:0061617 | MICOS complex(GO:0061617) |
2.9 | 8.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
2.8 | 33.7 | GO:0016580 | Sin3 complex(GO:0016580) |
2.6 | 7.8 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
2.5 | 17.7 | GO:0000439 | core TFIIH complex(GO:0000439) |
2.5 | 10.0 | GO:0072487 | MSL complex(GO:0072487) |
2.4 | 9.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
2.4 | 19.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
2.4 | 33.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
2.4 | 35.3 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
2.3 | 23.2 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
2.2 | 20.0 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
2.1 | 8.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
2.1 | 8.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
2.1 | 33.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
2.0 | 6.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
2.0 | 10.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
2.0 | 12.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
2.0 | 9.9 | GO:0005683 | U7 snRNP(GO:0005683) |
1.9 | 33.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
1.9 | 14.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
1.8 | 9.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.8 | 7.3 | GO:0035363 | histone locus body(GO:0035363) |
1.8 | 26.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.7 | 19.2 | GO:0032039 | integrator complex(GO:0032039) |
1.7 | 3.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.7 | 6.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.7 | 5.1 | GO:0070822 | Sin3-type complex(GO:0070822) |
1.7 | 11.8 | GO:0005869 | dynactin complex(GO:0005869) |
1.7 | 34.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
1.6 | 6.6 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
1.6 | 12.9 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.6 | 20.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.6 | 6.3 | GO:1990745 | EARP complex(GO:1990745) |
1.5 | 7.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.5 | 20.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
1.5 | 6.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.5 | 8.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
1.5 | 4.4 | GO:0000322 | storage vacuole(GO:0000322) |
1.5 | 11.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
1.5 | 5.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.4 | 11.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
1.4 | 14.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
1.4 | 5.6 | GO:0035339 | SPOTS complex(GO:0035339) |
1.4 | 11.1 | GO:0071439 | clathrin complex(GO:0071439) |
1.4 | 10.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
1.4 | 4.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
1.3 | 5.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.3 | 6.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.3 | 41.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.3 | 9.0 | GO:0043596 | nuclear replication fork(GO:0043596) |
1.3 | 3.8 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.3 | 10.2 | GO:0031209 | SCAR complex(GO:0031209) |
1.2 | 68.7 | GO:0005643 | nuclear pore(GO:0005643) |
1.2 | 7.4 | GO:0001940 | male pronucleus(GO:0001940) |
1.2 | 6.2 | GO:0034709 | methylosome(GO:0034709) |
1.2 | 9.5 | GO:0070652 | HAUS complex(GO:0070652) |
1.2 | 3.6 | GO:0055087 | Ski complex(GO:0055087) |
1.2 | 3.5 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
1.2 | 14.0 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
1.2 | 85.0 | GO:0005814 | centriole(GO:0005814) |
1.2 | 11.6 | GO:0031011 | Ino80 complex(GO:0031011) |
1.2 | 13.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
1.1 | 2.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
1.1 | 14.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
1.1 | 5.6 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.1 | 7.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.1 | 4.3 | GO:0071797 | LUBAC complex(GO:0071797) |
1.1 | 2.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.0 | 9.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.0 | 22.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
1.0 | 7.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.0 | 4.0 | GO:0030870 | Mre11 complex(GO:0030870) |
1.0 | 16.1 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
1.0 | 2.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.0 | 1.9 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.9 | 10.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.9 | 2.8 | GO:1990423 | RZZ complex(GO:1990423) |
0.9 | 2.8 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
0.9 | 17.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.9 | 5.5 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.9 | 5.4 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.9 | 7.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.9 | 1.8 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.9 | 22.2 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.9 | 9.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.9 | 1.8 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.9 | 26.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.9 | 11.1 | GO:0010369 | chromocenter(GO:0010369) |
0.9 | 14.5 | GO:0030904 | retromer complex(GO:0030904) |
0.8 | 7.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.8 | 1.7 | GO:0097255 | R2TP complex(GO:0097255) |
0.8 | 36.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.8 | 8.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.8 | 8.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.8 | 3.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.8 | 23.0 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.8 | 9.0 | GO:0030894 | replisome(GO:0030894) |
0.8 | 21.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.8 | 15.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.8 | 72.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.8 | 2.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.8 | 5.4 | GO:0012505 | endomembrane system(GO:0012505) |
0.8 | 26.3 | GO:0016592 | mediator complex(GO:0016592) |
0.8 | 7.7 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.7 | 5.9 | GO:0000346 | transcription export complex(GO:0000346) |
0.7 | 2.2 | GO:0016589 | NURF complex(GO:0016589) |
0.7 | 2.2 | GO:0000235 | astral microtubule(GO:0000235) |
0.7 | 14.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.7 | 2.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.7 | 5.0 | GO:0034464 | BBSome(GO:0034464) |
0.7 | 24.8 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.7 | 41.7 | GO:0000776 | kinetochore(GO:0000776) |
0.7 | 2.8 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.7 | 28.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.7 | 45.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.7 | 21.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.7 | 2.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.7 | 4.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.7 | 1.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.7 | 3.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.6 | 9.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.6 | 31.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.6 | 1.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.6 | 5.6 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.6 | 35.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.6 | 3.6 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.6 | 24.8 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.6 | 6.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.6 | 7.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.6 | 9.8 | GO:0002102 | podosome(GO:0002102) |
0.6 | 4.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.6 | 4.0 | GO:0051286 | cell tip(GO:0051286) |
0.6 | 10.1 | GO:0015030 | Cajal body(GO:0015030) |
0.5 | 0.5 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.5 | 1.1 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.5 | 61.5 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.5 | 2.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.5 | 9.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.5 | 8.7 | GO:0051233 | spindle midzone(GO:0051233) |
0.5 | 27.1 | GO:0098800 | inner mitochondrial membrane protein complex(GO:0098800) |
0.5 | 12.2 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.5 | 1.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 1.5 | GO:0097433 | dense body(GO:0097433) |
0.5 | 6.5 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.5 | 9.9 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.5 | 2.5 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.5 | 57.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.5 | 5.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.5 | 23.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.5 | 1.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.5 | 7.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.5 | 0.9 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.5 | 17.7 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.5 | 3.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.5 | 5.1 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.5 | 0.9 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.5 | 1.8 | GO:1990130 | Iml1 complex(GO:1990130) |
0.4 | 4.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.4 | 3.6 | GO:0071564 | npBAF complex(GO:0071564) |
0.4 | 0.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.4 | 17.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.4 | 2.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.4 | 24.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 20.5 | GO:0016605 | PML body(GO:0016605) |
0.4 | 0.9 | GO:0001939 | female pronucleus(GO:0001939) |
0.4 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.4 | 48.1 | GO:0000139 | Golgi membrane(GO:0000139) |
0.4 | 10.6 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.4 | 35.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.4 | 89.0 | GO:0005813 | centrosome(GO:0005813) |
0.4 | 2.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.4 | 1.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 4.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.4 | 94.2 | GO:0005874 | microtubule(GO:0005874) |
0.4 | 2.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.4 | 20.1 | GO:0005795 | Golgi stack(GO:0005795) |
0.4 | 4.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.4 | 1.2 | GO:0031415 | NatA complex(GO:0031415) |
0.4 | 11.9 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.4 | 1.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.4 | 15.1 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.4 | 0.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.4 | 1.9 | GO:0072687 | meiotic spindle(GO:0072687) |
0.4 | 5.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.4 | 2.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.4 | 1.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.4 | 0.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.4 | 16.3 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.4 | 37.6 | GO:0005770 | late endosome(GO:0005770) |
0.4 | 2.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 1.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.4 | 6.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 0.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.4 | 1.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 1.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 2.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 4.0 | GO:0044447 | axoneme part(GO:0044447) |
0.3 | 13.2 | GO:0005840 | ribosome(GO:0005840) |
0.3 | 1.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 82.6 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.3 | 1.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 1.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.3 | 2.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 0.3 | GO:0012506 | vesicle membrane(GO:0012506) |
0.3 | 0.6 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 3.8 | GO:0031672 | A band(GO:0031672) |
0.3 | 34.2 | GO:0031965 | nuclear membrane(GO:0031965) |
0.3 | 0.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.3 | 1.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.3 | 10.9 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 9.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.3 | 8.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.3 | 239.6 | GO:0005739 | mitochondrion(GO:0005739) |
0.3 | 1.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 0.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 238.1 | GO:0005829 | cytosol(GO:0005829) |
0.3 | 1.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 0.8 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.3 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 1.1 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.3 | 5.3 | GO:0030684 | preribosome(GO:0030684) |
0.3 | 2.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 0.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.3 | 9.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 0.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 0.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 0.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 0.2 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 72.8 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 0.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.5 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.2 | 22.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 2.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 2.7 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.2 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 136.9 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 6.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 3.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 0.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.2 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 3.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 48.3 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 1.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 2.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 4.0 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.2 | 115.2 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.2 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 3.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 2.0 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 2.3 | GO:0005819 | spindle(GO:0005819) |
0.2 | 9.3 | GO:0031514 | motile cilium(GO:0031514) |
0.2 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.2 | 3.8 | GO:0010008 | endosome membrane(GO:0010008) |
0.2 | 4.8 | GO:1990234 | transferase complex(GO:1990234) |
0.2 | 305.8 | GO:0005634 | nucleus(GO:0005634) |
0.2 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.8 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 1.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.9 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.3 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.1 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.1 | 3.6 | GO:0044431 | Golgi apparatus part(GO:0044431) |
0.1 | 0.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.6 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 1.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.4 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 2.0 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.1 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.2 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.1 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.0 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.1 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.0 | 1.7 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.8 | GO:0005929 | cilium(GO:0005929) |
0.0 | 0.0 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.0 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 1.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
0.0 | 76.1 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 7.2 | GO:0097708 | intracellular vesicle(GO:0097708) |
0.0 | 0.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 0.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.0 | GO:1990777 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.0 | 2.1 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.1 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 35.8 | GO:0005622 | intracellular(GO:0005622) |
0.0 | 0.1 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 28.5 | GO:0000403 | Y-form DNA binding(GO:0000403) |
6.9 | 20.7 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
6.5 | 19.5 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
5.3 | 15.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
4.8 | 9.7 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
4.8 | 23.8 | GO:0070728 | leucine binding(GO:0070728) |
4.4 | 35.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
4.3 | 17.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
4.2 | 16.7 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
3.8 | 19.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
3.7 | 11.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
3.5 | 17.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
3.4 | 10.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
3.3 | 20.1 | GO:0052630 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
3.3 | 9.9 | GO:0071209 | U7 snRNA binding(GO:0071209) |
3.3 | 9.9 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
3.3 | 26.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
3.2 | 13.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
3.2 | 9.6 | GO:0035514 | DNA demethylase activity(GO:0035514) |
3.2 | 16.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
3.0 | 3.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
3.0 | 14.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
2.9 | 17.4 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
2.8 | 14.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
2.8 | 31.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
2.8 | 8.3 | GO:0055100 | adiponectin binding(GO:0055100) |
2.7 | 10.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
2.7 | 13.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
2.6 | 23.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
2.6 | 15.6 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
2.6 | 7.7 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
2.4 | 24.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
2.4 | 7.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
2.4 | 7.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
2.4 | 14.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
2.3 | 14.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
2.3 | 20.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
2.3 | 16.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.2 | 4.4 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
2.2 | 6.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
2.2 | 6.6 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
2.2 | 6.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
2.1 | 6.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
2.1 | 17.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
2.1 | 8.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
2.0 | 5.9 | GO:0030621 | U4 snRNA binding(GO:0030621) |
1.9 | 13.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
1.9 | 11.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.9 | 13.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
1.9 | 15.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.9 | 28.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
1.9 | 5.6 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
1.9 | 9.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.9 | 27.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
1.9 | 5.6 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.8 | 5.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.8 | 5.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.7 | 5.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.7 | 8.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.6 | 3.3 | GO:0070840 | dynein complex binding(GO:0070840) |
1.5 | 45.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.5 | 19.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.5 | 5.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.5 | 13.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
1.5 | 4.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
1.4 | 7.0 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.4 | 17.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
1.4 | 12.3 | GO:0016004 | phospholipase activator activity(GO:0016004) |
1.4 | 1.4 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
1.3 | 4.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.3 | 14.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
1.3 | 18.5 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
1.3 | 5.2 | GO:0030911 | TPR domain binding(GO:0030911) |
1.3 | 5.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
1.3 | 5.1 | GO:0009374 | biotin binding(GO:0009374) |
1.3 | 15.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
1.2 | 5.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.2 | 7.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.2 | 8.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.2 | 14.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
1.2 | 7.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.2 | 3.5 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
1.2 | 26.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.2 | 6.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.1 | 4.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.1 | 5.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.1 | 6.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.1 | 11.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
1.1 | 3.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.1 | 2.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
1.1 | 19.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.1 | 10.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.1 | 16.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.1 | 5.3 | GO:0017040 | ceramidase activity(GO:0017040) |
1.0 | 6.2 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.0 | 23.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
1.0 | 3.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.0 | 4.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
1.0 | 4.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.0 | 14.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
1.0 | 20.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
1.0 | 21.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
1.0 | 3.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.0 | 2.0 | GO:1990188 | euchromatin binding(GO:1990188) |
1.0 | 6.9 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
1.0 | 18.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
1.0 | 6.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.0 | 22.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.0 | 4.8 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
1.0 | 12.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.9 | 4.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.9 | 2.8 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.9 | 6.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.9 | 2.8 | GO:0036033 | mediator complex binding(GO:0036033) |
0.9 | 2.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.9 | 3.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.9 | 17.5 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.9 | 1.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.9 | 1.8 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.9 | 8.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.9 | 7.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.9 | 2.7 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.9 | 3.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.9 | 1.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.9 | 6.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.9 | 12.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.9 | 4.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.9 | 7.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.9 | 0.9 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.9 | 6.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.9 | 2.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.9 | 1.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.9 | 2.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.9 | 0.9 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.8 | 4.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.8 | 3.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.8 | 7.5 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.8 | 7.5 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.8 | 0.8 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.8 | 8.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.8 | 6.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.8 | 0.8 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.8 | 2.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.8 | 7.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.8 | 4.7 | GO:0000150 | recombinase activity(GO:0000150) |
0.8 | 2.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.8 | 5.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.8 | 5.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.8 | 2.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.8 | 28.5 | GO:0000049 | tRNA binding(GO:0000049) |
0.8 | 4.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.8 | 24.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.8 | 14.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.8 | 4.5 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.8 | 57.2 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.7 | 15.0 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.7 | 10.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.7 | 2.2 | GO:0019961 | interferon binding(GO:0019961) |
0.7 | 2.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.7 | 2.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.7 | 12.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.7 | 3.6 | GO:0016151 | nickel cation binding(GO:0016151) |
0.7 | 5.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.7 | 4.1 | GO:0046790 | virion binding(GO:0046790) |
0.7 | 4.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.7 | 2.0 | GO:0000182 | rDNA binding(GO:0000182) |
0.7 | 19.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.7 | 10.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.7 | 4.7 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.7 | 34.4 | GO:0002039 | p53 binding(GO:0002039) |
0.7 | 6.0 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.7 | 14.6 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.7 | 4.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.7 | 14.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.7 | 7.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.7 | 19.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.6 | 3.9 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.6 | 16.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.6 | 21.7 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.6 | 7.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.6 | 1.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.6 | 3.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.6 | 3.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.6 | 7.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.6 | 3.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.6 | 8.0 | GO:0046961 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.6 | 15.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.6 | 2.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.6 | 2.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.6 | 5.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.6 | 3.6 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.6 | 7.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.6 | 1.2 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.6 | 22.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.6 | 7.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.6 | 4.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.6 | 6.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.6 | 2.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.6 | 1.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.6 | 32.3 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.6 | 1.7 | GO:0015232 | heme transporter activity(GO:0015232) |
0.5 | 22.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.5 | 17.0 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.5 | 4.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.5 | 1.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.5 | 2.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.5 | 15.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.5 | 3.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.5 | 2.6 | GO:0019113 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.5 | 1.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.5 | 1.5 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.5 | 1.5 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.5 | 1.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.5 | 1.0 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.5 | 2.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.5 | 2.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 2.0 | GO:0097001 | ceramide binding(GO:0097001) |
0.5 | 2.0 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.5 | 3.5 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.5 | 2.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.5 | 9.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.5 | 9.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.5 | 1.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 87.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.5 | 3.8 | GO:0031386 | protein tag(GO:0031386) |
0.5 | 1.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.5 | 4.7 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.5 | 3.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.5 | 12.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.4 | 0.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.4 | 2.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.4 | 0.4 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.4 | 7.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 1.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.4 | 1.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 13.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.4 | 5.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 2.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 0.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.4 | 9.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.4 | 0.4 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.4 | 1.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 2.9 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.4 | 118.4 | GO:0005525 | GTP binding(GO:0005525) |
0.4 | 28.4 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.4 | 0.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 1.7 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 2.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.4 | 4.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.4 | 8.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.4 | 5.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 0.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 2.0 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.4 | 2.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.4 | 0.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.4 | 33.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.4 | 7.9 | GO:0008875 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.4 | 5.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 1.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.4 | 1.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.4 | 1.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 1.5 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.4 | 252.5 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.4 | 1.5 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.4 | 21.0 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.4 | 1.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 1.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.4 | 50.2 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.4 | 5.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.4 | 7.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.4 | 1.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.4 | 1.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 0.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.4 | 1.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 1.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.4 | 0.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 1.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.4 | 2.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.4 | 0.4 | GO:0051379 | epinephrine binding(GO:0051379) |
0.3 | 8.3 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.3 | 30.9 | GO:0000149 | SNARE binding(GO:0000149) |
0.3 | 6.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 1.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 3.0 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.3 | 1.0 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.3 | 2.0 | GO:0005536 | glucose binding(GO:0005536) |
0.3 | 14.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 2.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 14.9 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.3 | 1.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.3 | 15.8 | GO:0008565 | protein transporter activity(GO:0008565) |
0.3 | 0.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.3 | 12.8 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.3 | 3.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.3 | 1.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.3 | 1.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.3 | 51.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.3 | 4.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 1.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.3 | 1.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 2.5 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.3 | 1.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 0.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 9.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 0.9 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 1.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.3 | 0.9 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.3 | 4.9 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.3 | 1.8 | GO:0070628 | proteasome binding(GO:0070628) |
0.3 | 9.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 1.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 6.6 | GO:0051117 | ATPase binding(GO:0051117) |
0.3 | 1.2 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 2.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 1.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.3 | 14.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.3 | 15.8 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.3 | 0.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 0.9 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.3 | 2.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 1.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 0.9 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.3 | 1.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 1.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.3 | 0.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 0.3 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.3 | 0.9 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.3 | 0.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 0.8 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 10.4 | GO:0051087 | chaperone binding(GO:0051087) |
0.3 | 0.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 1.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.3 | 0.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 3.0 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.3 | 0.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 1.9 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.3 | 1.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.3 | 4.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 76.3 | GO:0017111 | nucleoside-triphosphatase activity(GO:0017111) |
0.3 | 2.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.3 | 1.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 13.6 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.3 | 0.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 2.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 3.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.3 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 0.8 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 0.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 1.0 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 12.9 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.3 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 2.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 0.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 2.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 7.4 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.2 | 1.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.2 | 5.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 8.9 | GO:0018169 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.2 | 11.4 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.2 | 1.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 0.7 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 3.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.5 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 5.8 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 15.2 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.2 | 2.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 0.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 0.7 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 2.1 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 0.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 3.1 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.2 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 0.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.2 | 3.7 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.2 | 0.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 43.5 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.2 | 13.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 3.6 | GO:0019239 | deaminase activity(GO:0019239) |
0.2 | 1.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.4 | GO:0015923 | mannosidase activity(GO:0015923) |
0.2 | 0.2 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 0.2 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.2 | 5.3 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 0.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.2 | 15.5 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.2 | 0.2 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.2 | 1.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 0.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 0.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 2.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 1.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 14.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 0.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 0.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 0.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 0.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 0.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.2 | 0.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 1.8 | GO:0015250 | water channel activity(GO:0015250) |
0.2 | 2.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 1.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 0.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 3.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 0.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 5.0 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 1.2 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.2 | 1.5 | GO:0043176 | amine binding(GO:0043176) |
0.2 | 1.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 0.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 3.9 | GO:0016209 | antioxidant activity(GO:0016209) |
0.2 | 1.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 0.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 7.1 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 0.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 0.3 | GO:0060229 | lipase activator activity(GO:0060229) |
0.2 | 0.7 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 1.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 1.0 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.2 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 1.9 | GO:0050661 | NADP binding(GO:0050661) |
0.2 | 0.6 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 1.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 0.5 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.2 | 0.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 17.3 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.2 | 1.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 0.2 | GO:0061733 | peptide N-acetyltransferase activity(GO:0034212) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.2 | 1.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 25.4 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.1 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.1 | 2.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.6 | GO:0055102 | phospholipase inhibitor activity(GO:0004859) lipase inhibitor activity(GO:0055102) |
0.1 | 10.7 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 1.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 19.6 | GO:0001664 | G-protein coupled receptor binding(GO:0001664) |
0.1 | 2.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.7 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.1 | 0.7 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 1.1 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 1.5 | GO:0016462 | pyrophosphatase activity(GO:0016462) |
0.1 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 1.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 153.2 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 2.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 1.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.4 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.3 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 1.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 2.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.2 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 1.6 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 0.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 1.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 2.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 3.3 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 0.2 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.1 | 1.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 1.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.4 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 1.2 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.1 | 0.1 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.1 | 0.3 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.1 | 0.1 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.7 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 1.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 16.3 | GO:0019901 | protein kinase binding(GO:0019901) |
0.1 | 0.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.4 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.8 | GO:0018448 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 2.2 | GO:0019900 | kinase binding(GO:0019900) |
0.1 | 0.1 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.1 | 0.3 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.4 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 5.9 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.4 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.4 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 1.9 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.4 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 1.1 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 31.8 | GO:0005524 | ATP binding(GO:0005524) |
0.1 | 0.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.2 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 6.5 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.1 | 1.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.3 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 7.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.4 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.8 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.1 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 3.7 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 1.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.1 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.3 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 2.4 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 0.3 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.1 | 1.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.1 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.1 | 0.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.6 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.6 | GO:0032813 | tumor necrosis factor receptor binding(GO:0005164) tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.4 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.0 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.0 | 0.6 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.0 | 0.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.2 | GO:0017016 | Ras GTPase binding(GO:0017016) |
0.0 | 0.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.1 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.0 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.2 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.4 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.0 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.0 | 7.3 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0034920 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.0 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 1.5 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.0 | 0.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.5 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.0 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.0 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 0.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.0 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.1 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.0 | 0.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.0 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.0 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.0 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.1 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 23.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.7 | 29.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.7 | 37.3 | PID MYC PATHWAY | C-MYC pathway |
1.4 | 11.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.3 | 27.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.3 | 42.6 | PID ATR PATHWAY | ATR signaling pathway |
1.1 | 25.8 | ST GAQ PATHWAY | G alpha q Pathway |
1.1 | 10.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.0 | 18.6 | PID ATM PATHWAY | ATM pathway |
0.9 | 14.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.9 | 11.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.9 | 31.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.8 | 16.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.8 | 6.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.8 | 40.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.8 | 4.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.7 | 12.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.7 | 13.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.7 | 14.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.7 | 36.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.6 | 20.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.6 | 10.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.6 | 7.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.6 | 0.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 22.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.6 | 7.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.6 | 15.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.5 | 15.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 21.2 | PID P73PATHWAY | p73 transcription factor network |
0.5 | 14.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.5 | 11.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 7.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.4 | 8.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.4 | 6.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 2.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 11.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 6.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.3 | 6.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 6.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 7.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.3 | 2.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 2.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 2.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 1.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 1.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 0.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 5.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 5.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 7.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 1.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 1.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 0.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 0.4 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 1.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 3.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 0.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 0.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 2.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 4.3 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 5.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 4.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 1.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 9.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 2.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 2.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 2.7 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 0.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 3.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 1.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 28.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
2.6 | 30.9 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
2.6 | 28.3 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
2.0 | 105.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
1.8 | 9.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.8 | 19.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.8 | 31.5 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
1.7 | 32.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
1.6 | 14.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.5 | 7.7 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
1.5 | 19.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
1.4 | 24.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
1.4 | 2.7 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
1.3 | 10.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.3 | 10.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
1.3 | 20.5 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
1.3 | 14.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.2 | 2.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
1.2 | 4.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.2 | 13.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.1 | 8.0 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.1 | 18.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.1 | 79.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.0 | 18.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.0 | 8.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.0 | 20.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.0 | 19.8 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
1.0 | 27.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
1.0 | 91.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
1.0 | 20.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.0 | 16.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.9 | 42.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.9 | 2.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.9 | 24.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.9 | 8.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.8 | 6.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.8 | 22.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.8 | 4.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.8 | 7.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.7 | 11.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.7 | 11.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.7 | 2.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.7 | 9.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.7 | 19.6 | REACTOME TRANSLATION | Genes involved in Translation |
0.7 | 3.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.7 | 56.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.7 | 4.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.7 | 0.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.7 | 13.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.6 | 6.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.6 | 13.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.6 | 8.0 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.6 | 6.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.6 | 5.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.6 | 7.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.6 | 8.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.6 | 5.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.6 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.6 | 7.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.6 | 14.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.5 | 3.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.5 | 12.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.5 | 12.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.5 | 8.0 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.5 | 18.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.5 | 8.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.5 | 3.0 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.5 | 8.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.5 | 5.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.5 | 5.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.5 | 5.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.5 | 1.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.5 | 12.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 5.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.5 | 4.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.4 | 3.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.4 | 10.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.4 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 3.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.4 | 5.5 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.4 | 6.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 5.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.4 | 9.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.4 | 5.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.4 | 9.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.4 | 5.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.4 | 8.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.4 | 2.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.4 | 6.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 3.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 2.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 21.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.4 | 2.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.4 | 8.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 6.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.4 | 1.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 3.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 1.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.3 | 1.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 4.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.3 | 7.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 2.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 1.9 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.3 | 1.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 13.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 1.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.3 | 5.9 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.3 | 0.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.3 | 6.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.3 | 4.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 3.5 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.3 | 2.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 16.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 9.2 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.3 | 5.4 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.3 | 3.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 6.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 2.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 2.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 3.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 26.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 4.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 2.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 2.0 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 1.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 4.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 1.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 8.3 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 0.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 2.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 0.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 15.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 2.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 1.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 0.2 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.2 | 2.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 0.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 0.6 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.2 | 2.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 4.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 4.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 9.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 2.1 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 2.9 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 3.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.9 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 2.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 2.4 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 1.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 1.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 1.0 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.1 | 1.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 4.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 0.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 5.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.6 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.2 | REACTOME TRANSCRIPTION | Genes involved in Transcription |
0.1 | 0.4 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.1 | 0.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.4 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 0.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 0.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 1.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 5.7 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 0.8 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.6 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.0 | REACTOME S PHASE | Genes involved in S Phase |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.2 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |